These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 9700580

  • 1. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.
    al-Shabanah OA, Badary OA, Nagi MN, al-Gharably NM, al-Rikabi AC, al-Bekairi AM.
    J Exp Clin Cancer Res; 1998 Jun; 17(2):193-8. PubMed ID: 9700580
    [Abstract] [Full Text] [Related]

  • 2. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
    El-Ashmawy NE, Khedr EG, Ebeid EM, Salem ML, Zidan AA, Mosalam EM.
    Eur J Pharm Sci; 2017 Nov 15; 109():525-532. PubMed ID: 28890201
    [Abstract] [Full Text] [Related]

  • 3. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
    Jagetia GC, Reddy TK, Malagi KJ, Nayak BS, Naidu MB, Ravikiran PB, Kamath SU, Shetty PC, Reddy DS.
    Phytother Res; 2005 Sep 15; 19(9):772-8. PubMed ID: 16220569
    [Abstract] [Full Text] [Related]

  • 4. Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma.
    Ali SA, Zaitone SA, Moustafa YM.
    Can J Physiol Pharmacol; 2015 Aug 15; 93(8):695-708. PubMed ID: 26230640
    [Abstract] [Full Text] [Related]

  • 5. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
    El-Demerdash E, Ali AA, Sayed-Ahmed MM, Osman AM.
    Cancer Chemother Pharmacol; 2003 Nov 15; 52(5):411-6. PubMed ID: 12879278
    [Abstract] [Full Text] [Related]

  • 6. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
    Forrest GL, Gonzalez B, Tseng W, Li X, Mann J.
    Cancer Res; 2000 Sep 15; 60(18):5158-64. PubMed ID: 11016643
    [Abstract] [Full Text] [Related]

  • 7. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M, Sala V, De Santis MC, Cimino J, Cappello P, Pianca N, Di Bona A, Margaria JP, Martini M, Lazzarini E, Pirozzi F, Rossi L, Franco I, Bornbaum J, Heger J, Rohrbach S, Perino A, Tocchetti CG, Lima BHF, Teixeira MM, Porporato PE, Schulz R, Angelini A, Sandri M, Ameri P, Sciarretta S, Lima-Júnior RCP, Mongillo M, Zaglia T, Morello F, Novelli F, Hirsch E, Ghigo A.
    Circulation; 2018 Aug 14; 138(7):696-711. PubMed ID: 29348263
    [Abstract] [Full Text] [Related]

  • 8. A Chemosensitizer Drug: Disulfiram Prevents Doxorubicin-Induced Cardiac Dysfunction and Oxidative Stress in Rats.
    Sonawane VK, Mahajan UB, Shinde SD, Chatterjee S, Chaudhari SS, Bhangale HA, Ojha S, Goyal SN, Kundu CN, Patil CR.
    Cardiovasc Toxicol; 2018 Oct 14; 18(5):459-470. PubMed ID: 29779119
    [Abstract] [Full Text] [Related]

  • 9. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY, Najjar TA, Alashari M.
    J Biochem Mol Toxicol; 2004 Oct 14; 18(2):78-86. PubMed ID: 15122649
    [Abstract] [Full Text] [Related]

  • 10. Biocompatible microemulsion modifies the pharmacokinetic profile and cardiotoxicity of doxorubicin.
    Assumpção JU, Campos ML, Ferraz Nogueira Filho MA, Pestana KC, Baldan HM, Formariz Pilon TP, de Oliveira AG, Peccinini RG.
    J Pharm Sci; 2013 Jan 14; 102(1):289-96. PubMed ID: 23150468
    [Abstract] [Full Text] [Related]

  • 11. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats.
    Elberry AA, Abdel-Naim AB, Abdel-Sattar EA, Nagy AA, Mosli HA, Mohamadin AM, Ashour OM.
    Food Chem Toxicol; 2010 May 14; 48(5):1178-84. PubMed ID: 20146931
    [Abstract] [Full Text] [Related]

  • 12. Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice.
    Adwas AA, Elkhoely AA, Kabel AM, Abdel-Rahman MN, Eissa AA.
    J Infect Chemother; 2016 Jan 14; 22(1):36-43. PubMed ID: 26603425
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice.
    Badary OA, Al-Shabanah OA, Al-Gharably NM, Elmazar MM.
    Anticancer Drugs; 1998 Oct 14; 9(9):809-15. PubMed ID: 9840728
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the pharmacokinetics and cardiotoxicity of doxorubicin in rat receiving nilotinib.
    Zhou ZY, Wan LL, Yang QJ, Han YL, Li Y, Yu Q, Guo C, Li X.
    Toxicol Appl Pharmacol; 2013 Oct 01; 272(1):238-44. PubMed ID: 23770382
    [Abstract] [Full Text] [Related]

  • 16. Hesperidin alleviates doxorubicin-induced cardiotoxicity in rats.
    Abdel-Raheem IT, Abdel-Ghany AA.
    J Egypt Natl Canc Inst; 2009 Jun 01; 21(2):175-84. PubMed ID: 21057569
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo.
    Zhang SH, Wang WQ, Wang JL.
    Acta Pharmacol Sin; 2009 Nov 01; 30(11):1479-87. PubMed ID: 19890356
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats.
    Badary OA, Abdel-Naim AB, Abdel-Wahab MH, Hamada FM.
    Toxicology; 2000 Mar 07; 143(3):219-26. PubMed ID: 10755708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.